Skip to content

Reaching UNAIDS HIV treatment targets could avert millions of deaths and new infections

New drug holds out promise of long-term control or even cure of HIV

HIV PEP with emtricitabine/tenofovir/rilpivirine has excellent completion and adherence rates

HIV-positive patients in Africa do well on three second-line ART regimens

South Africa: Women of lower socio-economic status have greater needs for services to prevent mother-to-child HIV transmission

One step further towards an HIV vaccine: and this one performed as expected

Our 10K superstars

Our 10K superstars

Second-line ART patients reach viral re-suppression following intensified adherence support

Black market for Truvada PrEP may undermine treatment adherence in marginalised people living with HIV